Get the Stockscreener App
7.0617
4.62%
0.3117
Burning Rock Biotech Ltd Adr stock is traded at $7.0617, with a volume of 385.
It is up +4.62% in the last 24 hours and up +16.91% over the past month.
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
See More
Previous Close:
$6.75
Open:
$7.05
24h Volume:
385
Relative Volume:
0.01
Market Cap:
$69.25M
Revenue:
$79.32M
Net Income/Loss:
$-100.37M
P/E Ratio:
-6.6047
EPS:
-1.0692
Net Cash Flow:
$-44.34M
1W Performance:
+0.29%
1M Performance:
+16.91%
6M Performance:
+13.99%
1Y Performance:
-27.12%
1-Day Range:
$7.05
$7.12
1-Week Range:
$6.40
$7.325
52-Week Range:
$2.62
$9.987
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
Name
Burning Rock Biotech Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare BNR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNR
Burning Rock Biotech Ltd Adr
|
7.12 | 69.25M | 79.32M | -100.37M | -44.34M | -0.98 |
|
TMO
Thermo Fisher Scientific Inc
|
524.38 | 198.99B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
231.09 | 165.80B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
133.72 | 38.37B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
196.22 | 35.67B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.71 | 33.85B | 3.84B | 866.24M | 792.60M | 10.37 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jul-07-20 | Initiated | Cowen | Outperform |
Burning Rock Biotech Ltd Adr Stock (BNR) Latest News
Burning Rock Announces Results of 2024 Annual General Meeting - GlobeNewswire Inc.
Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Canada Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech CFO Leo Li resigns - Investing.com
Burning Rock Biotech Limited Announces the Resignation of Leo Li as Chief Financial Officer - Marketscreener.com
Brazil Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock (BNR) in Focus: Stock Moves 5.4% Higher - Yahoo Movies UK
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - US-China Institute
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
BioLine Rx (NASDAQ:BLRX) Stock Quotes, Forecast and News Summary - Benzinga
Burning Rock Biotech (BNR) Stock Price, News & Analysis - MarketBeat
Citi Appointed Depositary Bank for Burning Rock Biotech Limited’s Sponsored ADR Program - Business Wire
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga
Burning Rock Biotech Ltd Adr Stock (BNR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
2.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):